Contrastingly, Frühbeck et al. demonstrated significant reduced circulating kallistatin in human obesity, and SERPINA4 gene expression levels were downregulated in the liver of obese patients with NAFLD (47). The gene discussed is SERPINA4; the disease is obesity due to melanocortin 4 receptor deficiency.